Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis
Outpatient autologous stem cell transplantations (ASCTs) in multiple myeloma and lymphoma patients have been shown to reduce the overall costs and improve the quality of life relative to inpatient ASCTs. This ...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Weerapat Owattanapanich, Kittima Suphadirekkul, Chutima Kunacheewa, Patompong Ungprasert and Kannadit Prayongratana Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants